Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia

Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia

Thitipon Yaowaluk1, Vorapun Senanarong2, Chanin Limwongse3, Rasda Boonprasert4, Pornpimol Kijsanayotin1 1Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; 2Division of Neurology, Department of Medicine, Faculty of Medicine, Si...

Full description

Bibliographic Details
Main Authors: Yaowaluk T, Senanarong V, Limwongse C, Boonprasert R, Kijsanayotin P
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
donepezil
CYP2D6 polymorphisms
concomitant drugs treatment
Alzheimer’s disease
vascular dementia
Online Access:https://www.dovepress.com/influence-of-cyp2d6-cyp3a5-abcb1-apoe-polymorphisms-and-nongenetic-fac-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/influence-of-cyp2d6-cyp3a5-abcb1-apoe-polymorphisms-and-nongenetic-fac-peer-reviewed-article-PGPM

Similar Items